TY - JOUR
T1 - Baricitinib for previously treated moderate or severe rheumatoid arthritis: an evidence review group perspective of a NICE single technology appraisal
JO - PharmacoEconomics
UR - https://eprints.whiterose.ac.uk/id/eprint/126812
PY - 2018/07/01
AU - Ren S
AU - Bermejo I
AU - Simpson E
AU - Wong R
AU - Scott D
AU - Young A
AU - Stevenson M
ED -
DO - DOI: 10.1007/s40273-018-0616-7
PB - Adis
VL - 36
SP - 769
EP - 778
Y2 - 2025/07/06
ER -